Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06010433 · ClinicalTrials.gov registry record

CERAMENT G Device Registry

A clinical trial of Diabetic Foot Osteomyelitis and Chronic Osteomyelitis, sponsored by Bonesupport AB.

Recruiting
Registry status
100
Enrollment target
3
Study locations

NCT06010433: Recruiting study of Diabetic Foot Osteomyelitis and Chronic Osteomyelitis, sponsored by Bonesupport AB.

NCT06010433 is a study of Diabetic Foot Osteomyelitis and Chronic Osteomyelitis that is actively recruiting participants, run by Bonesupport AB. The registered enrollment target is 100 participants. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06010433, a study of Diabetic Foot Osteomyelitis and Chronic Osteomyelitis, is actively recruiting participants, sponsored by Bonesupport AB.

RECRUITING
Registry status
100 participants
Enrollment target
3
Study locations

Study Summary

This is an Observational Device Registry Study of CERAMENT\|G in normal use in accordance with the IFU. It will run for a period of three years from enrolment of the first patient into the Study at each Site, before being subject to review. A Device Registry is a form of observational study that concerns the performance of a device in normal use. It is intended to collect data that is reflective of 'real world' device performance.

Primary Outcome

• Device safety - any unexpected device performance, complaints, adverse events, adverse device effects, SAEs throughout study period.

Interventions

  • DEVICE CERAMENT G

Study Locations (3)

California

  • North Park Podiatry - San Diego

North Carolina

  • OrthoCarolina - Charlotte

Ohio

  • University Hospitals Cleveland Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-08-17
Est. Completion 2028-09-22
Bonesupport AB

3 total trials

What NCT06010433 shows while recruiting

NCT06010433 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 3 conditions, with Diabetic Foot Osteomyelitis appearing as the primary indexed condition, and to 1 intervention - of which CERAMENT G is the first listed.

NCT06010433 reports a single indexed study location in California, North Carolina, Ohio.

Frequently Asked Questions

What is clinical trial NCT06010433 about?

NCT06010433 is a clinical study titled "CERAMENT G Device Registry". This is an Observational Device Registry Study of CERAMENT\|G in normal use in accordance with the IFU. It will run for a period of three years from enrolment of the first patient into the Study at each Site, before being subject to review. A Device Registry is a form of observational study that con...

What is the current status of trial NCT06010433?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-08-17. Estimated completion is 2028-09-22.

What conditions does trial NCT06010433 study?

This clinical trial studies the following conditions: Diabetic Foot Osteomyelitis, Chronic Osteomyelitis, Fracture Related Infection.

What interventions are being tested in trial NCT06010433?

The interventions under investigation include: CERAMENT G (DEVICE).

Who is sponsoring clinical trial NCT06010433?

This trial is sponsored by Bonesupport AB, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06010433 being conducted?

This trial has 3 study locations across California, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Foot Osteomyelitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06010433, the US trial registry maintained by the National Library of Medicine. NCT06010433 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.